BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 28544312)

  • 1. C-X-C motif chemokine receptor 4 promotes tumor angiogenesis in gastric cancer via activation of JAK2/STAT3.
    Zhang Q; Xu F; Shi Y; Chen YW; Wang HP; Yu X; Li Y
    Cell Biol Int; 2017 Aug; 41(8):854-862. PubMed ID: 28544312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CXCL1 promotes tumor growth through VEGF pathway activation and is associated with inferior survival in gastric cancer.
    Wei ZW; Xia GK; Wu Y; Chen W; Xiang Z; Schwarz RE; Brekken RA; Awasthi N; He YL; Zhang CH
    Cancer Lett; 2015 Apr; 359(2):335-43. PubMed ID: 25641338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-17 promotes tumor angiogenesis through Stat3 pathway mediated upregulation of VEGF in gastric cancer.
    Wu X; Yang T; Liu X; Guo JN; Xie T; Ding Y; Lin M; Yang H
    Tumour Biol; 2016 Apr; 37(4):5493-501. PubMed ID: 26566627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Epigallocatechin-3-gallate inhibits growth and angiogenesis of gastric cancer and its molecular mechanism].
    Zhu BH; Zhan WH; He YL; Cai SR; Wang Z; Zhang CH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Jan; 12(1):82-5. PubMed ID: 19145512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRH promotes human colon cancer cell proliferation via IL-6/JAK2/STAT3 signaling pathway and VEGF-induced tumor angiogenesis.
    Fang X; Hong Y; Dai L; Qian Y; Zhu C; Wu B; Li S
    Mol Carcinog; 2017 Nov; 56(11):2434-2445. PubMed ID: 28618089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. JAK2/STAT3 signaling pathway activation mediates tumor angiogenesis by upregulation of VEGF and bFGF in non-small-cell lung cancer.
    Zhao M; Gao FH; Wang JY; Liu F; Yuan HH; Zhang WY; Jiang B
    Lung Cancer; 2011 Sep; 73(3):366-74. PubMed ID: 21333372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EphA3 contributes to tumor growth and angiogenesis in human gastric cancer cells.
    Lv XY; Wang J; Huang F; Wang P; Zhou JG; Wei B; Li SH
    Oncol Rep; 2018 Oct; 40(4):2408-2416. PubMed ID: 30066881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (-)-Epigallocatechin-3-gallate inhibits growth of gastric cancer by reducing VEGF production and angiogenesis.
    Zhu BH; Zhan WH; Li ZR; Wang Z; He YL; Peng JS; Cai SR; Ma JP; Zhang CH
    World J Gastroenterol; 2007 Feb; 13(8):1162-9. PubMed ID: 17451194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of JAK2/STAT3 signaling pathway on angiogenesis in non-small cell lung cancer].
    Zhao M; Liu F; Wang JY; Zhang WY; Gao FH; Jiang B
    Zhonghua Yi Xue Za Zhi; 2011 Feb; 91(6):375-81. PubMed ID: 21418908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-451 acts as a suppressor of angiogenesis in hepatocellular carcinoma by targeting the IL-6R-STAT3 pathway.
    Liu X; Zhang A; Xiang J; Lv Y; Zhang X
    Oncol Rep; 2016 Sep; 36(3):1385-92. PubMed ID: 27461244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA PVT1 promotes angiogenesis via activating the STAT3/VEGFA axis in gastric cancer.
    Zhao J; Du P; Cui P; Qin Y; Hu C; Wu J; Zhou Z; Zhang W; Qin L; Huang G
    Oncogene; 2018 Jul; 37(30):4094-4109. PubMed ID: 29706652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-204 deregulation in lung adenocarcinoma controls the biological behaviors of endothelial cells potentially by modulating Janus kinase 2-signal transducer and activator of transcription 3 pathway.
    Liu X; Gao X; Zhang W; Zhu T; Bi W; Zhang Y
    IUBMB Life; 2018 Jan; 70(1):81-91. PubMed ID: 29281186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of STAT3 signaling pathway by nitidine chloride suppressed the angiogenesis and growth of human gastric cancer.
    Chen J; Wang J; Lin L; He L; Wu Y; Zhang L; Yi Z; Chen Y; Pang X; Liu M
    Mol Cancer Ther; 2012 Feb; 11(2):277-87. PubMed ID: 22203730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The inhibition effects of apatinib on cell proliferation, migration and apoptosis in esophageal carcinoma via Ras/Raf/MEK/ERK and JAK2/STAT3 pathways].
    Feng Y; Zhou MY; Sun F; Kong Z; Wang J; Sun ZQ; Hu LJ; Wang JL; Hua Q; Yu JP
    Zhonghua Zhong Liu Za Zhi; 2019 Apr; 41(4):263-275. PubMed ID: 31014051
    [No Abstract]   [Full Text] [Related]  

  • 15. Nef-M1, a peptide antagonist of CXCR4, inhibits tumor angiogenesis and epithelial‑to‑mesenchymal transition in colon and breast cancers.
    Katkoori VR; Basson MD; Bond VC; Manne U; Bumpers HL
    Oncotarget; 2015 Sep; 6(29):27763-77. PubMed ID: 26318034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melanoma cell-secreted exosomal miR-155-5p induce proangiogenic switch of cancer-associated fibroblasts via SOCS1/JAK2/STAT3 signaling pathway.
    Zhou X; Yan T; Huang C; Xu Z; Wang L; Jiang E; Wang H; Chen Y; Liu K; Shao Z; Shang Z
    J Exp Clin Cancer Res; 2018 Oct; 37(1):242. PubMed ID: 30285793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-6 secreted by cancer-associated fibroblasts promotes epithelial-mesenchymal transition and metastasis of gastric cancer via JAK2/STAT3 signaling pathway.
    Wu X; Tao P; Zhou Q; Li J; Yu Z; Wang X; Li J; Li C; Yan M; Zhu Z; Liu B; Su L
    Oncotarget; 2017 Mar; 8(13):20741-20750. PubMed ID: 28186964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CXCR4/CXCL12 axis promotes VEGF-mediated tumor angiogenesis through Akt signaling pathway.
    Liang Z; Brooks J; Willard M; Liang K; Yoon Y; Kang S; Shim H
    Biochem Biophys Res Commun; 2007 Aug; 359(3):716-22. PubMed ID: 17559806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of STAT3 is involved in malignancy mediated by CXCL12-CXCR4 signaling in human breast cancer.
    Liu X; Xiao Q; Bai X; Yu Z; Sun M; Zhao H; Mi X; Wang E; Yao W; Jin F; Zhao L; Ren J; Wei M
    Oncol Rep; 2014 Dec; 32(6):2760-8. PubMed ID: 25310198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-874 functions as a tumor suppressor by inhibiting angiogenesis through STAT3/VEGF-A pathway in gastric cancer.
    Zhang X; Tang J; Zhi X; Xie K; Wang W; Li Z; Zhu Y; Yang L; Xu H; Xu Z
    Oncotarget; 2015 Jan; 6(3):1605-17. PubMed ID: 25596740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.